H.C. Wainwright Reiterates Buy Rating on Cocrystal Pharma, Inc. (COCP)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 1.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $0.92 | |||
| Open | $1.07 | 52 Week Low | $0.32 | |||
| Day High | $1.07 | P/E | N/A | |||
| Day Low | $1.07 | EPS | $-0.18 | |||
| Volume | 71,969 | |||||
